SYAB.DE
Price:
$11.06
Market Cap:
$2.43B
SYNLAB AG provides clinical laboratory and medical diagnostic services for insurance companies, hospitals, pharmacies, national health organizations, practicing doctors, clinics, patients, governments, and corporations primarily in Europe. The company offers Coronavirus tests, and medical and veterinary diagnostics services. It operates through approximately 500 laboratories and 1,800 blood collection points in 36 countries in four continents. The company was founded in 1998 and is headquartered in Munich, Germany.
Industry
Medical - Diagnostics & Research
IPO Date
2021-04-30
Stock Exchange
XETRA
Ticker
SYAB.DE
According to SYNLAB AG’s latest financial reports and current stock price. The company's current PE Ratio is 27.65. This represents a change of 78.14% compared to the average of 15.52 of the last 4 quarters.
The mean historical PE Ratio of SYNLAB AG over the last ten years is -105.04. The current 27.65 PE Ratio has changed -2732.42% with respect to the historical average. Over the past ten years (40 quarters), SYAB.DE's PE Ratio was at its highest in in the June 2023 quarter at 41.15. The PE Ratio was at its lowest in in the June 2020 quarter at -180.52.
Average
-105.04
Median
-98.77
Minimum
-506.58
Maximum
112.69
Discovering the peaks and valleys of SYNLAB AG PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 223.09%
Maximum Annual PE Ratio = 112.69
Minimum Annual Increase = -152.88%
Minimum Annual PE Ratio = -506.58
Year | PE Ratio | Change |
---|---|---|
2023 | 27.19 | 63.25% |
2022 | 16.66 | 104.95% |
2021 | 8.13 | -92.79% |
2020 | 112.69 | -152.88% |
2019 | -213.10 | -57.93% |
2018 | -506.58 | 223.09% |
2017 | -156.79 | 58.75% |
2016 | -98.77 | -26.70% |
The current PE Ratio of SYNLAB AG (SYAB.DE) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
17.33
5-year avg
-9.69
10-year avg
-105.04
SYNLAB AG’s PE Ratio is greater than SUSE S.A. (-52.56), greater than Dermapharm Holding SE (16.11), greater than Shop Apotheke Europe N.V. (-54.48), less than Hensoldt AG (78.02), greater than Traton SE (6.00),
Company | PE Ratio | Market cap |
---|---|---|
-52.56 | $1.85B | |
16.11 | $1.83B | |
-54.48 | $1.61B | |
78.02 | $8.43B | |
6.00 | $15.08B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like SYNLAB AG using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like SYNLAB AG or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is SYNLAB AG's PE Ratio?
How is the PE Ratio calculated for SYNLAB AG (SYAB.DE)?
What is the highest PE Ratio for SYNLAB AG (SYAB.DE)?
What is the 3-year average PE Ratio for SYNLAB AG (SYAB.DE)?
What is the 5-year average PE Ratio for SYNLAB AG (SYAB.DE)?
How does the current PE Ratio for SYNLAB AG (SYAB.DE) compare to its historical average?